Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 7, 2006; 12(41): 6707-6710
Published online Nov 7, 2006. doi: 10.3748/wjg.v12.i41.6707
Published online Nov 7, 2006. doi: 10.3748/wjg.v12.i41.6707
Table 1 Demographic data of patients and controls
Demographic data | Patients | Controls |
Gender (M/F) | 20/48 | 12/28 |
Median age (min-max) | 41 (20-77) | 38 (20-68) |
Esophagitis | ||
Grade A | 80.90% | - |
Grade B | 14.70% | - |
Grade C | 4.40% | - |
Grade D | - | - |
Table 2 Esophageal symptoms in patients with reflux disease (n = 68)
Symptoms | n (%) |
Heartburn | 48 (70.6) |
Chest pain | 40 (58.8) |
Regurgitation | 48 (70.6) |
Bleeding | 5 (7.4) |
Dysphagia | 3 (4.4) |
Odynophagia | 2 (3.0) |
Pulmonary symptoms | 10 (14.7) |
Others (diarrhea…) | 11 (16.2) |
Table 3 Prevalence of positive serologic markers for coeliac disease according to the esophagitis grade (n = 68)
Grades | Antigliadin IgA | Antigliadin IgG | Antiendomysium IgA | |||
n | % | n | % | n | % | |
Grade A (n = 55) | 4 | 7.2 | 3 | 5.4 | - | - |
Grade B (n = 10) | 1 | 10 | 2 | 20 | - | - |
Grade C (n = 3) | 1 | 33.3 | 2 | 66.6 | - | - |
Table 4 Prevalence of positive serologic markers for coeliac disease in control subjects (n = 40)
Serologic markers | Control subjects (n = 40) | |
n | % | |
Antigliadin IgA | 4 | 10 |
Antigliadin IgG | 3 | 7.5 |
Antiendomysium IgA | - | - |
- Citation: Bagcı S, Ercin CN, Yesilova Z, Ozcan A, Degertekin B, Dagalp K. Levels of serologic markers of celiac disease in patients with reflux esophagitis. World J Gastroenterol 2006; 12(41): 6707-6710
- URL: https://www.wjgnet.com/1007-9327/full/v12/i41/6707.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i41.6707